FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174367176> ?p ?o ?g. }

• W3174367176 abstract "Background: Immune-related adverse events (irAEs) are secondary reactions related to treatment with immune checkpoint inhibitors (ICIs). There have been six cases published reporting on an association between patients undergoing treatment with ICIs and the occurrence of acquired thrombotic thrombocytopenic purpura (TTP). Case report: We report a 61-year-old male receiving treatment with chemoimmunotherapy followed by pembrolizumab maintenance therapy for advanced non-small-cell lung cancer, presenting with bleeding symptoms, anemia, and thrombocytopenia. The patient received pembrolizumab seven times in total, in three-week cycles. Laboratory testing demonstrated hemolytic anemia, which, in combination with other findings, suggested thrombotic microangiopathy (TMA). PLASMIC scoring and specialized testing with ADAMTS13 activity and inhibitor confirmed a diagnosis of TTP. The patient was started on therapy with plasmapheresis and glucocorticoids, resulting in clinical improvement. The patient chose to leave the hospital under the care of home hospice and died approximately one month after being discharged. Conclusions: Of the six cases of ICI-induced TTP, only one other was treated with pembrolizumab to our knowledge to date. Our patient experienced an adverse reaction marked by thrombocytopenia and hematuria after drug exposure. With symptom improvement after ICI discontinuation and recurrence on readministration, a presumptive diagnosis of ICI-associated TTP was made. This case report and literature review emphasize the need for close observation of patients undergoing ICI therapy for potential rare irAEs. The further investigation aimed at the study of risk factors, disease severity, and treatment response to this form of secondary TTP is needed to guide treatment decisions." @default.
• W3174367176 created "2021-07-05" @default.
• W3174367176 creator A5005176077 @default.
• W3174367176 creator A5047845515 @default.
• W3174367176 creator A5048107967 @default.
• W3174367176 creator A5062371651 @default.
• W3174367176 creator A5090660463 @default.
• W3174367176 date "2021-06-29" @default.
• W3174367176 modified "2023-10-16" @default.
• W3174367176 title "Immune Checkpoint Inhibitor-Associated Thrombotic Thrombocytopenic Purpura in a Patient With Metastatic Non-Small-Cell Lung Cancer" @default.
• W3174367176 cites W1934685709 @default.
• W3174367176 cites W2067978628 @default.
• W3174367176 cites W2092997044 @default.
• W3174367176 cites W2586675028 @default.
• W3174367176 cites W2588793467 @default.
• W3174367176 cites W2605728624 @default.
• W3174367176 cites W2906233636 @default.
• W3174367176 cites W2984521008 @default.
• W3174367176 cites W3003958677 @default.
• W3174367176 cites W3006654174 @default.
• W3174367176 cites W3023745224 @default.
• W3174367176 cites W3038774038 @default.
• W3174367176 cites W3094816744 @default.
• W3174367176 cites W3095103520 @default.
• W3174367176 cites W3097660838 @default.
• W3174367176 cites W3122877358 @default.
• W3174367176 doi "https://doi.org/10.7759/cureus.16035" @default.
• W3174367176 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8321598" @default.
• W3174367176 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34345535" @default.
• W3174367176 hasPublicationYear "2021" @default.
• W3174367176 type Work @default.
• W3174367176 sameAs 3174367176 @default.
• W3174367176 citedByCount "3" @default.
• W3174367176 countsByYear W31743671762022 @default.
• W3174367176 crossrefType "journal-article" @default.
• W3174367176 hasAuthorship W3174367176A5005176077 @default.
• W3174367176 hasAuthorship W3174367176A5047845515 @default.
• W3174367176 hasAuthorship W3174367176A5048107967 @default.
• W3174367176 hasAuthorship W3174367176A5062371651 @default.
• W3174367176 hasAuthorship W3174367176A5090660463 @default.
• W3174367176 hasBestOaLocation W31743671761 @default.
• W3174367176 hasConcept C121608353 @default.
• W3174367176 hasConcept C126322002 @default.
• W3174367176 hasConcept C141071460 @default.
• W3174367176 hasConcept C159654299 @default.
• W3174367176 hasConcept C197934379 @default.
• W3174367176 hasConcept C203014093 @default.
• W3174367176 hasConcept C2776256026 @default.
• W3174367176 hasConcept C2776309230 @default.
• W3174367176 hasConcept C2777385706 @default.
• W3174367176 hasConcept C2777701055 @default.
• W3174367176 hasConcept C2777878052 @default.
• W3174367176 hasConcept C2778248108 @default.
• W3174367176 hasConcept C2778585876 @default.
• W3174367176 hasConcept C2778715236 @default.
• W3174367176 hasConcept C2778842783 @default.
• W3174367176 hasConcept C2779134260 @default.
• W3174367176 hasConcept C2779338263 @default.
• W3174367176 hasConcept C2779771385 @default.
• W3174367176 hasConcept C2780057760 @default.
• W3174367176 hasConcept C2780653079 @default.
• W3174367176 hasConcept C2780931953 @default.
• W3174367176 hasConcept C2781127562 @default.
• W3174367176 hasConcept C65245452 @default.
• W3174367176 hasConcept C71924100 @default.
• W3174367176 hasConcept C89560881 @default.
• W3174367176 hasConceptScore W3174367176C121608353 @default.
• W3174367176 hasConceptScore W3174367176C126322002 @default.
• W3174367176 hasConceptScore W3174367176C141071460 @default.
• W3174367176 hasConceptScore W3174367176C159654299 @default.
• W3174367176 hasConceptScore W3174367176C197934379 @default.
• W3174367176 hasConceptScore W3174367176C203014093 @default.
• W3174367176 hasConceptScore W3174367176C2776256026 @default.
• W3174367176 hasConceptScore W3174367176C2776309230 @default.
• W3174367176 hasConceptScore W3174367176C2777385706 @default.
• W3174367176 hasConceptScore W3174367176C2777701055 @default.
• W3174367176 hasConceptScore W3174367176C2777878052 @default.
• W3174367176 hasConceptScore W3174367176C2778248108 @default.
• W3174367176 hasConceptScore W3174367176C2778585876 @default.
• W3174367176 hasConceptScore W3174367176C2778715236 @default.
• W3174367176 hasConceptScore W3174367176C2778842783 @default.
• W3174367176 hasConceptScore W3174367176C2779134260 @default.
• W3174367176 hasConceptScore W3174367176C2779338263 @default.
• W3174367176 hasConceptScore W3174367176C2779771385 @default.
• W3174367176 hasConceptScore W3174367176C2780057760 @default.
• W3174367176 hasConceptScore W3174367176C2780653079 @default.
• W3174367176 hasConceptScore W3174367176C2780931953 @default.
• W3174367176 hasConceptScore W3174367176C2781127562 @default.
• W3174367176 hasConceptScore W3174367176C65245452 @default.
• W3174367176 hasConceptScore W3174367176C71924100 @default.
• W3174367176 hasConceptScore W3174367176C89560881 @default.
• W3174367176 hasLocation W31743671761 @default.
• W3174367176 hasLocation W31743671762 @default.
• W3174367176 hasOpenAccess W3174367176 @default.
• W3174367176 hasPrimaryLocation W31743671761 @default.
• W3174367176 hasRelatedWork W17016037 @default.
• W3174367176 hasRelatedWork W2018501430 @default.
• W3174367176 hasRelatedWork W2039732273 @default.
• W3174367176 hasRelatedWork W2096103309 @default.
• W3174367176 hasRelatedWork W2619798956 @default.

• next